<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03708913</url>
  </required_header>
  <id_info>
    <org_study_id>H16-01595</org_study_id>
    <nct_id>NCT03708913</nct_id>
  </id_info>
  <brief_title>Neuromodulation for Hypothalamic Obesity</brief_title>
  <official_title>Deep Brain Stimulation for Hypothalamic Obesity: A Surgical &amp; Neuroimaging Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of British Columbia</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of British Columbia</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      The balance between hunger and satiety is imperative for an individual's survival and overall
      health.). Without this balance, individuals can become morbidly obese or lack adequate
      nutrition for survival. Craniopharyngioma (CP) is a benign tumour that occurs at the base of
      the brain in children. Unfortunately, pediatric neurosurgeons sometimes inadvertently destroy
      a child's satiety centre during CP tumour removal surgery. This leaves the child with a
      post-operative complication: an insatiable appetite. This form of obesity is called
      &quot;hypothalamic obesity&quot;. This study is designed to investigate Deep Brain Stimulation for
      hypothalamic obesity in n=6 young adults who have stabilized tumours.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      For young adults with destroyed satiety centres due to childhood CP surgery, we believe
      directly re-balancing the brain's control of hunger and satiety is necessary for sustained
      and long-term therapy. n=6 patients will be recruited in this Phase 1 DBS trial. The proposed
      research will hope to improve personal health among the young adults involved in this study
      by improving quality of life and avoiding long-term cardiovascular morbidities. Furthermore,
      this study will elucidate what brain regions drive excessive hunger and develop a treatment
      that attempts to reverse these abnormalities.
    </textblock>
  </detailed_description>
  <overall_status>Withdrawn</overall_status>
  <why_stopped>
    no participants have been able to qualify for study
  </why_stopped>
  <start_date type="Anticipated">June 2019</start_date>
  <completion_date type="Anticipated">April 2020</completion_date>
  <primary_completion_date type="Anticipated">December 2019</primary_completion_date>
  <phase>Phase 1</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Number of Participants With Adverse Events That Are Related to surgery and Post-Operative Side Effects</measure>
    <time_frame>12 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Body Mass Index (BMI)</measure>
    <time_frame>12 months</time_frame>
    <description>Measuring BMI(kg/m^2) following 12 months of constant stimulation</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Hyperphagia Questionnaire</measure>
    <time_frame>12 months</time_frame>
    <description>Completion of hyperphagia questionnaire</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>SF-36 Quality of Life Questionnaire</measure>
    <time_frame>12 months</time_frame>
    <description>Completion of QoL Questionnaire</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">0</enrollment>
  <condition>Craniopharyngioma</condition>
  <condition>Hypothalamic Obesity</condition>
  <condition>Metabolic Syndrome</condition>
  <arm_group>
    <arm_group_label>Open-Label Lateral Hypothalamic DBS Stimulation</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Open-label lateral hypothalamic DBS stimulation for 1 year.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Hypothalamic Deep Brain Stimulation</intervention_name>
    <description>One-year continuous hypothalamic deep brain stimulation</description>
    <arm_group_label>Open-Label Lateral Hypothalamic DBS Stimulation</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Diagnosed with hypothalamic obesity following craniopharyngioma tumour removal

          -  Treatment refractory to pharmacological interventions such as growth hormone therapy
             and anti-obesity medications

        Exclusion Criteria:

          -  Unable to give consent or unmanaged psychiatric condition
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>30 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <reference>
    <citation>Lustig RH. Hypothalamic obesity after craniopharyngioma: mechanisms, diagnosis, and treatment. Front Endocrinol (Lausanne). 2011 Nov 3;2:60. doi: 10.3389/fendo.2011.00060. eCollection 2011.</citation>
    <PMID>22654817</PMID>
  </reference>
  <reference>
    <citation>Lustig RH. Hypothalamic obesity: causes, consequences, treatment. Pediatr Endocrinol Rev. 2008 Dec;6(2):220-7. Review.</citation>
    <PMID>19202508</PMID>
  </reference>
  <reference>
    <citation>Lustig RH, Post SR, Srivannaboon K, Rose SR, Danish RK, Burghen GA, Xiong X, Wu S, Merchant TE. Risk factors for the development of obesity in children surviving brain tumors. J Clin Endocrinol Metab. 2003 Feb;88(2):611-6.</citation>
    <PMID>12574189</PMID>
  </reference>
  <reference>
    <citation>Lustig RH, Rose SR, Burghen GA, Velasquez-Mieyer P, Broome DC, Smith K, Li H, Hudson MM, Heideman RL, Kun LE. Hypothalamic obesity caused by cranial insult in children: altered glucose and insulin dynamics and reversal by a somatostatin agonist. J Pediatr. 1999 Aug;135(2 Pt 1):162-8.</citation>
    <PMID>10431109</PMID>
  </reference>
  <reference>
    <citation>Ho AL, Sussman ES, Zhang M, Pendharkar AV, Azagury DE, Bohon C, Halpern CH. Deep Brain Stimulation for Obesity. Cureus. 2015 Mar 25;7(3):e259. doi: 10.7759/cureus.259. eCollection 2015 Mar. Review.</citation>
    <PMID>26180683</PMID>
  </reference>
  <verification_date>October 2018</verification_date>
  <study_first_submitted>December 8, 2016</study_first_submitted>
  <study_first_submitted_qc>October 15, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">October 17, 2018</study_first_posted>
  <last_update_submitted>October 15, 2018</last_update_submitted>
  <last_update_submitted_qc>October 15, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">October 17, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of British Columbia</investigator_affiliation>
    <investigator_full_name>Christopher Honey</investigator_full_name>
    <investigator_title>Professor &amp; Neurosurgeon</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Craniopharyngioma</mesh_term>
    <mesh_term>Adamantinoma</mesh_term>
    <mesh_term>Obesity</mesh_term>
    <mesh_term>Metabolic Syndrome</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

